Volume 202, Issue 3 , Page 207, March 2010
Latest research from the 2010 meeting of the Society for Maternal-Fetal Medicine
Article Outline
This month's issue includes 8 articles that describe research presented at the 2010 meeting of the Society for Maternal-Fetal Medicine (SMFM) in Chicago on February 4-6. From 1256 abstracts submitted, 86 were selected by the Society for oral presentation. Authors of these 86 abstracts were invited to submit their manuscripts through the “Fast-Track” process, in which AJOG reviewers provided rapid reviews in time to allow revision to meet the deadline for inclusion in this issue. These fast-track articles are easily identified by the checkered racing flags on the first page of each as well as next to their titles in the Contents section. We hope our readers will enjoy reading these articles based on oral presentations at the SMFM meeting and those that will appear in upcoming issues of the Journal.
See related editorials, pages 208 and 209, and articles, pages 239-255 and 292
In addition, 2 editorials in this issue discuss several of those papers. Associate Editor George A. Macones, MD, MSCE provides an overview of 3 studies of elective delivery prior to 39 weeks' gestation. Scott Grosse, PhD, senior health economist, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, discusses a study of the cost-effectiveness of prenatal screening for spinal muscular atrophy.
The Editors of the Journal and the SMFM Publications Committee thank the authors and reviewers for their diligence in submitting and evaluating these papers, identified on their title pages as SMFM oral presentations. The reviewers are listed below.
PII: S0002-9378(10)00099-2
doi:10.1016/j.ajog.2010.01.069
© 2010 Mosby, Inc. All rights reserved.
Refers to article:
-
Elective delivery before 39 weeks: reason for caution
-
What is the value for money of prenatal carrier screening for spinal muscular atrophy? Too soon to say
-


An international trial of antioxidants in the prevention of preeclampsia (INTAPP)
-


Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia
-


Magnesium sulfate reduces inflammation-associated brain injury in fetal mice
Volume 202, Issue 3 , Page 207, March 2010
